It's Tuesday, which means MD Biosciences is providing coverage of the latest fascinating and innovative discoveries happening all over the world across a wide variety of disciplinary areas. This week's blog is compiling posts from science journals including Gen News, Nature Microbiology, ScienceDaily, Marine Biological Laboratory and Nature Microbiology. Skim the titles below to catch up on what is happening and follow the links to read more about something that catches your eye!
Prostate cancer affects many men worldwide, and is almost as widespread as skin cancer among men. Current statistics indicate about 1 in every 9 men will be diagnosed with prostate cancer at some point in their lifetime. A research team at Yale University have discovered a possible new biomarker that can identify patients at risk for prostate cancer metastasis. Reported by The American Journal of Pathology.
Researchers at the University of Missouri believe a recent discovery could provide doctors with a way to trick neurons into thinking the body is still functioning normally. This could potentially allow for normal nerve function even after an injury. Learn more about this groundbreaking therapeutic treatment for spinal cord injuries by following the link. Reported by Gen News. MD Biosciences offers a novel, rapid in-vitro assay for the screening of compound effects in nerve injury, learn more by clicking below.
Just like our skin cells can feel the difference between a gentle breeze and a strong wind, some bacterial cells can sense flow changes, too. A research team at Princeton University discovered that some bacteria can in fact detect the speed of flow regardless of the force, creatively named "bacteria speedometers". Their paper appears in the online journal Nature Microbiology.
Antihistamine Drug Reverses Glioblastoma Growth
A murine study out of the University of Helsinki found that glioblastoma, the most aggressive form of brain cancer, can be halted by an antihistamine drug that is known to trigger cell death caused by leaky lysosomes. The team found an association between the fatty acid binding protein mammary-derived growth inhibitor (MDGI) and poorer prognosis in patients. Their work previously identified MDGI as a glioma biomarker of invasive gliomas, and linked increased expression of the protein with more severe glioma grade. Reported by Gen News. MD Biosciences offers advanced biomarker analytical capabilities, learn more below!
A study reported by the National Science Foundation discusses lampreys' ability to regenerate their spinal cord and completely recover function after the cord had been severed twice in the same location. The Marine Biological Laboratory team, led by Tissue Engineering Director Jennifer Morgan, is isolating descending neurons to evaluate their transcriptional profiles to assess gene activities with a goal of determining what makes some cells regenerate while others die in the spinal cord. Their works invites new avenues for developing regenerative models and identifying therapeutic targets for human spinal cord injuries. Reported by the Marine Biological Laboratory.
Hope you enjoyed this week's top finds! Check back next week for more and always feel free to reach out with study inquiries.